The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder

Patients with bipolar II disorder (BDII) have a higher prevalence rate of metabolic disturbance. Whether BDII itself, in addition to its current standard treatment, is a risk factor for metabolic syndrome warrants additional study. The dopamine receptor D3 (DRD3) gene, one of the candidate genes for...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ting-Ting, Chen, Shiou-Lan, Chang, Yun-Hsuan, Chen, Po-See, Chu, Chun-Hsien, Chen, Shih-Heng, Huang, San-Yuan, Tzeng, Nian-Sheng, Wang, Liang-Jen, Wang, Tzu-Yun, Li, Chia-Ling, Chung, Yi-Lun, Hsieh, Tsai-Hsin, Lee, I-Hui, Chen, Kao-Ching, Yang, Yen-Kuang, Hong, Jau-Shyong, Lu, Ru-Band, Lee, Sheng-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998429/
https://www.ncbi.nlm.nih.gov/pubmed/27310943
http://dx.doi.org/10.1097/MD.0000000000003488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998429/
https://www.ncbi.nlm.nih.gov/pubmed/27310943
http://dx.doi.org/10.1097/MD.0000000000003488

Ejemplares similares